The use of platelet-rich plasma combined with demineralized freeze-dried bone allograft in the treatment of periodontal endosseous defects: A report of two clinical cases

Journal of the American Dental Association

Volumn 141, Issue 8, 2010, Pages 967-978

  Markou, Nikolaos ^a   Pepelassi, Eudoxie ^b   Kotsovilis, Sotirios ^b   Vrotsos, Ioannis ^b   Vavouraki, Helen ^c   Stamatakis, Harry Charalabos ^b  

^a 401 Military Hospital of Athens   (Greece)

^b UNIVERSITY OF ATHENS   (Greece)

^c INSTITUTE OF NANOSCIENCE AND NANOTECHNOLOGY   (Greece)

Author keywords

Case report; Demineralized freeze dried bone allograft; Periodontal endosseous defects; Platelet rich plasma

Indexed keywords

EID: 77956052088     PISSN: 00028177     EISSN: None     Source Type: Journal    
DOI: 10.14219/jada.archive.2010.0310     Document Type: Article

References (56)

1. Whitman DH, Berry RL, Green DM. Platelet gel: an autologous alternative to fibrin glue with applications in oral and maxillofacial surgery. J Oral Maxillofac Surg 1997;55(11):1294-1299.
2. Marx RE, Carlson ER, Eichstaedt RM, Schimmele SR, Strauss JE, Georgeff KR. Platelet-rich plasma: growth factor enhancement for bone grafts. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1998;85(6): 638-646.
3. Sánchez AR, Sheridan PJ, Kupp LI. Is platelet-rich plasma the perfect enhancement factor? A current review. Int J Oral Maxillofac Implants 2003;18(1):93-103.
4. Kotsovilis S, Markou N, Pepelassi E, Nikolidakis D. The adjunctive use of platelet-rich plasma in the therapy of periodontal intraosseous defects: a systematic review. J Periodontal Res 2010;45(3):428-443.
5. Döri F, Huszár T, Nikolidakis D, Arweiler NB, Gera I, Sculean A. Effect of platelet-rich plasma on the healing of intra-bony defects treated with a natural bone mineral and a collagen membrane. J Clin Periodontal 2007;34(3):254-261.
6. Okuda K, Tai H, Tanabe K, et al. Platelet-rich plasma combined with a porous hydroxyapatite graft for the treatment of intrabony periodontal defects in humans: a comparative controlled clinical study. J Periodontal 2005;76(6):890-898.
7. Demir B, Şengün D, Berberoglu A. Clinical evaluation of plateletrich plasma and bioactive glass in the treatment of intra-bony defects. J Clin Periodontal 2007;34(8):709-715.
8. Cheung WS, Griffin TJ. A comparative study of root coverage with connective tissue and platelet concentrate grafts: 8-month results. J Periodontal 2004;75(12):1678-1687.
9. Yen CA, Griffin TJ, Cheung WS, Chen J. Effects of platelet concentrate on palatal wound healing after connective tissue graft harvesting. J Periodontal 2007;78(4):601-610.
10. Simon D, Manuel S, Geetha V, Naik BR. Potential for osseous regeneration of platelet-rich plasma: a comparative study in mandibular third molar sockets. Indian J Dent Res 2004;15(4):133-136.
11. Lindeboom JA, Mathura KR, Aartman IH, Kroon FH, Milstein DM, Ince C. Influence of the application of platelet-enriched plasma in oral mucosal wound healing. Clin Oral Implants Res 2007;18(1): 133-139.
12. El-Sharkawy H, Kantarci A, Deady J, et al. Platelet-rich plasma: growth factors and pro- and anti-inflammatory properties. J Periodontal 2007;78(4):661-669.
13. Plachokova AS, Nikolidakis D, Mulder J, Jansen JA, Creugers NH. Effect of platelet-rich plasma on bone regeneration in dentistry: a systematic review. Clin Oral Implants Res 2008;19(6):539-545.
14. Trombelli L, Farina R. Clinical outcomes with bioactive agents alone or in combination with grafting or guided tissue regeneration. J Clin Periodontal 2008;35(suppl 8):117-135.
15. Piemontese M, Aspriello SD, Rubini C, Ferrante L, Procaccini M. Treatment of periodontal intrabony defects with demineralized freezedried bone allograft in combination with platelet-rich plasma: a comparative clinical trial. J Periodontal 2008;79(5):802-810.
16. Ilgenli T, Dündar N, Kal BI. Demineralized freeze-dried bone allograft and platelet-rich plasma vs platelet-rich plasma alone in infrabony defects: a clinical and radiographic evaluation. Clin Oral Investig 2007;11(1):51-59.
17. Markou N, Pepelassi E, Vavouraki H, et al. Treatment of periodontal endosseous defects with platelet-rich plasma alone or in combination with demineralized freeze-dried bone allograft: a comparative clinical trial. J Periodontal 2009;80(12):1911-1919.
18. Davie EW, Ratnoff OD. Waterfall sequence for intrinsic blood clotting. Science 1964;145(3638):1310-1312.
19. Diesen DL, Lawson JH. Bovine thrombin: history, use, and risk in the surgical patient. Vascular 2008;16(suppl 1):S29-S36.
20. O'Leary TJ, Drake RB, Naylor JE. The plaque control record. J Periodontal 1972;43(1):38.
21. Ainamo J, Bay I. Problems and proposals for recording gingivitis and plaque. Int Dent J 1975;25(4):229-235.
22. Armitage G. Development of a classification system for periodontal diseases and conditions. Ann Periodontal 1999;4(1):1-6.
23. Nyman S, Lindhe J, Lundgren D. The role of occlusion for the stability of fixed bridges in patients with reduced periodontal tissue support. J Clin Periodontal 1975;2(2):53-66.
24. Landesberg R, Moses M, Karpatkin M. Risks of using platelet rich plasma gel. J Oral Maxillofac Surg 1998;56(9):1116-1117.
25. Boyapati L, Wang HL. The role of platelet-rich plasma in sinus augmentation: a critical review. Implant Dent 2006;15(2):160-170.
26. American Society of Health System Pharmacists. AHFS Drug Information. 44th ed. Bethesda, Md.: American Society of Health System Pharmacists; 2002:1487.
27. Lomax C. Safety of topical thrombins: the ongoing debate. Patient Saf Surg 2009; 3(1):21.
28. Marx RE. Platelet-rich plasma: evidence to support its use. J Oral Maxillofac Surg 2004;62(4):489-496.
29. Dorion RP, Hamati HF, Landis B, Frey C, Heydt D, Carey D. Risk and clinical significance of developing antibodies induced by topical thrombin preparations. Arch Pathol Lab Med 1998;122(10):887-894.
30. Ortel TL, Mercer MC, Thames EH, Moore KD, Lawson JH. Immunologic impact and clinical outcomes after surgical exposure to bovine thrombin. Ann Surg 2001;233(1):88-96.
31. Schoenecker JG, Johnson RK, Lesher AP, et al. Exposure of mice to topical bovine thrombin induces systemic autoimmunity. Am J Pathol 2001;159(5):1957- 1969.
32. Cheng CM, Meyer-Massetti C, Kayser SR. A review of three stand-alone topical thrombins for surgical hemostasis. Clin Ther 2009; 31(1):32-41.
33. Ofosu FA, Crean S, Reynolds MW. A safety review of topical bovine thrombin-induced generation of antibodies to bovine proteins. Clin Ther 2009;31(4):679-691.
34. Lekovic V, Camargo PM, Weinlaender M, Vasilic N, Kenney EB. Comparison of platelet-rich plasma, bovine porous bone mineral, and guided tissue regeneration versus platelet-rich plasma and bovine porous bone mineral in the treatment of intrabony defects: a reentry study. J Periodontal 2002;73(2):198-205.
35. Camargo PM, Lekovic V, Weinlaender M, Vasilic N, Madzarevic M, Kenney EB. Platelet-rich plasma and bovine porous bone mineral combined with guided tissue regeneration in the treatment of intrabony defects in humans. J Periodontal Res 2002;37(4):300-306.
36. Lekovic V, Camargo PM, Weinlaender M, Vasilic N, Aleksic Z, Kenney EB. Effectiveness of a combination of platelet-rich plasma, bovine porous bone mineral and guided tissue regeneration in the treatment of mandibular grade II molar furcations in humans. J Clin Periodontal 2003;3(8):746-751.
37. Camargo PM, Lekovic V, Weinlaender M, Vasilic N, Madzarevic M, Kenney EB. A reentry study on the use of bovine porous bone mineral, GTR, and platelet-rich plasma in the regenerative treatment of intrabony defects in humans. Int J Periodontics Restorative Dent 2005; 25(1):49-59.
38. Camargo PM, Lekovic V, Weinlaender M, Divnic-Resnik T, Pavlovic M, Kenney EB. A surgical reentry study on the influence of platelet-rich plasma in enhancing the regenerative effects of bovine porous bone mineral and guided tissue regeneration in the treatment of intrabony defects in humans. J Periodontal 2009;80(6):915-923.
39. Hanna R, Trejo PM, Weltman RL. Treatment of intrabony defects with bovine-derived xenograft alone and in combination with plateletrich plasma: a randomized clinical trial. J Periodontal 2004;75(12): 1668-1677.
40. Don F, Huszár T, Nikolidakis D, Arweiler NB, Gera I, Sculean A. Effect of platelet-rich plasma on the healing of intrabony defects treated with an anorganic bovine bone mineral and expanded polytetrafluoroethylene membranes. J Periodontal 2007;78(6):983-990.
41. Dori F, Huszár T, Nikolidakis D, et al. Effect of platelet-rich plasma on the healing of intrabony defects treated with beta tricalcium phosphate and expanded polytetrafiuoroethylene membranes. J Periodontal 2008;79(4):660-669.
42. Döri F, Nikolidakis D, Húszár T, Arweiler NB, Gera I, Sculean A. Effect of platelet-rich plasma on the healing of intrabony defects treated with an enamel matrix protein derivative and a natural bone mineral. J Clin Periodontal 2008;35(1):44-50.
43. Dori F, Kovács V, Arweiler NB, et al. Effect of platelet-rich plasma on the healing of intrabony defects treated with an anorganic bovine bone mineral: a pilot study. J Periodontal 2009;80(10): 1599-1605.
44. Piemontese M, Aspriello SD, Rubini C, Ferrante L, Procaccini M. Treatment of periodontal intrabony defects with demineralized freezedried bone allograft in combination with platelet-rich plasma: a comparative clinical trial. J Periodontal 2008;79(5):802-810.
45. Eppley BL, Pietrzak WS, Blanton M. Platelet-rich plasma: a review of biology and applications in plastic surgery. Plast Reconstr Surg 2006;118(6):147e-159e.
46. Chapman WC, Singla N, Genyk Y, et al. A phase 3, randomized, double-blind comparative study of the efficacy and safety of topical recombinant human thrombin and bovine thrombin in surgical hemostasia. J Am Coll Surg 2007;205(2):256-265.
47. Doria C, Fischer CP, Wood CG, Li PM, Marra S, Hart J. Phase 3, randomized, double-blind study of plasma-derived human thrombin versus bovine thrombin in achieving hemostasis in patients undergoing surgery. Curr Med Res Opin 2008;24(3):785-794.
48. Singla NK, Ballard JL, Moneta G, Randleman CD Jr, Renkens KL, Alexander WA. A phase 3b, open-label, single-group immunogenicity and safety study of topical recombinant thrombin in surgical hemostasis. J Am Coll Surg 2009;209(1):68-74.
49. Papli R, Chen S. Surgical treatment of infrabony defects with autologous platelet concentrate or bioabsorbable barrier membrane: a prospective case series. J Periodontal 2007;78(1):185-193.
50. Harnack L, Boedeker RH, Kurtulus I, Boehm S, Gonzales J, Meyle J. Use of platelet-rich plasma in periodontal surgery: a prospective randomised double blind clinical trial. Clin Oral Investig 2009; 13(2):179-187.
51. Keceli HG, Sengun D, Berberoǧlu A, Karabulut E. Use of platelet gel with connective tissue grafts for root coverage: a randomized-controlled trial. J Clin Periodontal 2008;35(3):255-262.
52. Yilmaz S, Cakar G, Kuru B, Dirikan S, Yildirim B. Platelet-rich plasma in combination with bovine derived xenograft in the treatment of deep intrabony periodontal defects: a report of 20 consecutively treated patients. Platelets 2009;20(6):432-440.
53. Yilmaz S, Cakar G, Ipci SD, Kuru B, Yildirim B. Regenerative treatment with platelet-rich plasma combined with a bovine-derived xenograft in smokers and non-smokers: 12-month clinical and radiographic results. J Clin Periodontal 2010;37(1):80-87.
54. Consolo U, Zaffe D, Bertoldi C, Ceccherelli G. Platelet-rich plasma activity on maxillary sinus floor augmentation by autologous bone. Clin Oral Implants Res 2007;18(2):252-262.
55. Pradeep AR, Shetty SK, Garg G, Pai S. Clinical effectiveness of autologous platelet-rich plasma and peptide-enhanced bone graft in the treatment of intrabony defects. J Periodontal 2009;80(1):62-71.
56. Pradeep AR, Pai S, Garg G, Devi P, Shetty SK. A randomized clinical trial of autologous platelet-rich plasma in the treatment of mandibular degree II furcation defects. J Clin Periodontal 2009;36(7): 581-588.